D. Singh

发表

A comparison of plethysmography, spirometry and oscillometry for assessing the pulmonary effects of inhaled ipratropium bromide in healthy subjects and patients with asthma.

A. Woodcock, C. Houghton, D. Singh, 2005, British journal of clinical pharmacology.

Measuring bronchodilation in COPD clinical trials.

A. Woodcock, J. Vestbo, Z. Borrill, 2005, British journal of clinical pharmacology.

Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations.

P. Jones, J. Wedzicha, J. Vestbo, 2014, Respiratory medicine.

Exhaled breath condensate biomarkers in COPD

Z. Borrill, D. Singh, K. Roy, 2008, European Respiratory Journal.

Biomarkers of collagen turnover are related to annual change in FEV1 in patients with chronic obstructive pulmonary disease within the ECLIPSE study

L. Edwards, R. Zuwallack, J. Wedzicha, 2017, BMC Pulmonary Medicine.

Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial

H. Marshall, K. Kostikas, J. Wild, 2022, Respiratory Research.

New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management

P. Daley-Yates, E. Irusen, B. Aggarwal, 2022, Advances in Therapy.

Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent.

H. Bisgaard, B. Chawes, A. Døssing, 2014, Respiratory medicine.

A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients.

P. Barnes, B. Leaker, D. Singh, 2016, Pulmonary pharmacology & therapeutics.

The effect of gas standardisation on exhaled breath condensate pH

A. Woodcock, J. Smith, Z. Borrill, 2006, European Respiratory Journal.

Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study

I. Pavord, E. Bateman, N. Hanania, 2019, B21. SEVERE ASTHMA: CLINICAL AND MECHANISTIC STUDIES.

Plethysmography and impulse oscillometry assessment of tiotropium and ipratropium bromide; a randomized, double-blind, placebo-controlled, cross-over study in healthy subjects.

R. Tal-Singer, M. Goldman, D. Singh, 2006, British journal of clinical pharmacology.

When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals

J. Scullion, D. Singh, J. Roberts, 2019, International journal of chronic obstructive pulmonary disease.

A randomised, placebo- and active-controlled dose-finding study of aclidinium bromide administered twice a day in COPD patients.

H. Magnussen, C. Caracta, E. G. Gil, 2012, Pulmonary pharmacology & therapeutics.

The Combination of Indacaterol/Glycopyrronium/Mometasone Furoate Is Superior to High-Dose Salmeterol/Fluticasone Propionate in Improving Lung Function in Patients with Asthma

H. Watz, J. Hohlfeld, Z. Diamant, 2019, D101. CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD.

P55 Benefits of tiotropium/olodaterol on symptoms and health-related quality of life in patients with moderate to severe COPD with chronic bronchitis and/or emphysema

L. Bjermer, D. Singh, L. Grönke, 2016, Thorax.

P256 Aclidinium bromide: a Phase IIb, dose-finding study

H. Magnussen, C. Caracta, A. Kirsten, 2011, Thorax.

Normalization of Airflow Obstruction with Extra Fine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) pMDI: A Post-Hoc Analysis of the TRIMARAN and TRIGGER Studies

J. Virchow, A. Papi, W. Canonica, 2021 .

Persistent Airflow Limitation and the Risk for Moderate-Severe Asthma Exacerbations: A Post-Hoc Analysis of the TRIMARAN and TRIGGER Studies

J. Virchow, A. Papi, D. Singh, 2021 .

P271 Effect of extrafine single inhaler triple therapy on lung function and use of rescue medication: results from the trinity study

M. Corradi, A. Papi, S. Vezzoli, 2017, Thorax.

P273 Association of incident pneumonia and exacerbations with extrafine triple therapy in one single inhaler in copd patients: a post-hoc analysis from trilogy and trinity studies

M. Corradi, A. Papi, S. Vezzoli, 2017, Thorax.

A phase 2 study of the inhaled pan-JAK inhibitor TD-0903 in severe COVID-19: Part 1

A. Woodcock, E. Moran, R. Saggar, 2021, medRxiv.

Superiority of “triple” therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD

B. O'connor, A. Cahn, D. Singh, 2008, Thorax.

Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study

C. Porsbjerg, V. Backer, P. Berger, 2016, Respiratory Research.

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study

S. Lam, C. Porsbjerg, V. Backer, 2015, Respiratory Research.

Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials

D. Singh, J. Gray, D. Halpin, 2011, International journal of clinical practice.

Clinical characteristics and airway inflammation profile of COPD persistent sputum producers.

J. Vestbo, J. Plumb, D. Singh, 2014, Respiratory medicine.

Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications

A. Agustí, L. Lahousse, A. Papi, 2021, Allergy.

Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale

J. Smith, J. Vestbo, U. Kolsum, 2009, Thorax.

Use of different exhaled nitric oxide multiple flow rate models in COPD

Dave Singh, J. Vestbo, A. Hazel, 2007, European Respiratory Journal.

Dose responses for topical efficacy and systemic activity, dose equivalence and relative therapeutic index for fluticasone furoate (FF), fluticasone propionate (FP) and budesonide (BUD) in asthmatic subjects

Dave Singh, P. Daley-Yates, N. Brealey, 2019, Pneumologie.

Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease

J. Vestbo, Z. Borrill, D. Singh, 2005, European Respiratory Journal.

Outcomes Evaluated in Controlled Clinical Trials on the Management of COVID-19: A Methodological Systematic Review

P. Williamson, J. Vestbo, A. Hadi, 2020, medRxiv.

P250 Effects Of 12 Weeks Of Once-daily Tiotropium And Olodaterol Fixed-dose Combination On Exercise Endurance In Patients With Copd

R. Casaburi, F. Maltais, Dave Singh, 2014, Thorax.

Safety, Pharmacokinetics and Immunogenicity of the Anti-Interleukin-33 Antibody, Tozorakimab: Results of a Phase 1 Study in Healthy Adults and Patients with Chronic Obstructive Pulmonary Disease

D. Singh, R. Moate, E. Jiménez, 2022, B21. BASIC, CLINICAL, AND TRANSLATIONAL COPD STUDIES: THE ONGOING HUNT FOR UNDERLYING MECHANISMS AND THERAPEUTIC TARGETS.

Budesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalence.

A. Tutuncu, M. Carlholm, T. Polanowski, 2007, International journal of clinical pharmacology and therapeutics.

CD8 chemokine receptors in chronic obstructive pulmonary disease

J. Vestbo, D. Singh, L. Smyth, 2008, Clinical and experimental immunology.

P255 ATTAIN: twice-daily aclidinium bromide in patients with moderate to severe chronic obstructive pulmonary disease

P. Jones, E. Bateman, A. Agustí, 2011, Thorax.

Extrafine triple therapy reduces exacerbations in GOLD B COPD patients: post-hoc analysis of TRILOGY and TRINITY

Dave Singh, J. Vestbo, A. Papi, 2017, Pneumologie.